Table 4.
Comparison of G2, WD-G3, and PD neuroendocrine neoplasm cytologic features
Well differentiated G2 |
Well differentiated G3 |
Poorly differentiated |
P value | |
---|---|---|---|---|
Total (n=65) | 19 | 32 | 14 | |
Ki67% median (range) | 11% (3.2–17) | 40% (21–89) | 62% (25–95) | <.001 |
Large nuclear size No. (%) | 0 (0) | 3 (9) | 2 (14) | .2 |
Nuclear pleomorphism No. (%) | 1 (5) | 4 (13) | 7 (50) | .004 |
Round nucleus No. (%) | 14 (74) | 19 (59) | 3 (21) | .01 |
Smooth nucleus contour No. (%) | 18 (95) | 30 (94) | 9 (64) | .02 |
Angulated nuclei No. (%) | 3 (21) | 12 (38) | 12 (87) | <.001 |
Fine chromatin No. (%) | 3 (15) | 3 (4) | 1 (7) | .8 |
Single prominent nucleolus No. (%) | 1 (5) | 4 (13) | 2 (14) | .6 |
Plasmacytoid morphology No. (%) | 16 (84) | 24 (75) | 1 (7) | <.001 |
Abundant cytoplasm No. (%) | 11 (17) | 23 (72) | 3 (21) | .007 |
Nuclear tangles No. (%) | 8 (42) | 24 (75) | 13 (93) | .006 |
Molding No. (%) | 1 (5) | 3 (9) | 11 (79) | <.001 |
Apoptosis No. (%) | ||||
Present | 11 (58) | 28 (86) | 14 (100) | .005 |
>5/ 10 hpf | 3 (18) | 14 (44) | 11 (79) | .001 |
Mitoses No. (%) | ||||
Present | 10 (27) | 18 (56) | 9 (64) | .8 |
>5/10 hpf | 1 (5) | 6 (3) | 6 (43) | .03 |
Necrosis | 0 (0) | 4 (13) | 6 (43) | .003 |